Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
BMC Psychiatry|February 20, 2013
The MentDis_ICF65+ study protocol: prevalence, 1-year incidence and symptom severity of mental disorders in the elderly and their relationship to impairment, functioning (ICF) and service utilisationSylke Andreas, Martin Härter, Jana Volkert, et al.
International Psychogeriatrics|December 5, 2017
Predisposing, enabling, and need factors of service utilization in the elderly with mental health problemsJana Volkert, Sylke Andreas, Martin Härter, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|October 17, 2017
Anxiety Disorders in Old Age: Psychiatric Comorbidities, Quality of Life, and Prevalence According to Age, Gender, and CountryAlessandra Canuto, Kerstin Weber, Marc Baertschi, et al.
Health and Quality of Life Outcomes|March 8, 2020
Quality of life, level of functioning, and its relationship with mental and physical disorders in the elderly: results from the MentDis_ICF65+ studyLuigi Grassi, Rosangela Caruso, Chiara Da Ronch, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 1, 2025
Effects of anticoagulation in patients with device-detected atrial fibrillation and multiple stroke risk factors: a win ratio analysis of the NOAH-AFNET 6 trialNina Becher, Gina Köllner, Emanuele Bertaglia, et al.
Journal of the American Heart Association|August 27, 2024
Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 TrialHans Christoph Diener, Nina Becher, Susanne Sehner, et al.
The New England Journal of Medicine|August 25, 2023
Anticoagulation with Edoxaban in Patients with Atrial High-Rate EpisodesPaulus Kirchhof, Tobias Toennis, Andreas Goette, et al.
European Heart Journal|November 13, 2023
Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 hNina Becher, Tobias Toennis, Emanuele Bertaglia, et al.
European Heart Journal|September 2, 2024
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trialsRenate B Schnabel, Juan Benezet-Mazuecos, Nina Becher, et al.
Pageof 12